Xylem Inc. (XYL) to Issue $0.15 Quarterly Dividend
Xylem Inc. (NYSE:XYL) declared a quarterly dividend on Thursday, October 13th. Stockholders of record on Wednesday, November 9th will be paid a dividend of 0.1549 per share on Wednesday, December 7th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.25%.
Xylem (NYSE:XYL) opened at 49.66 on Friday. The company has a market capitalization of $8.90 billion, a P/E ratio of 26.51 and a beta of 1.15. Xylem has a one year low of $31.67 and a one year high of $53.25. The stock’s 50 day moving average price is $50.93 and its 200-day moving average price is $46.39.
Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.47 by $0.01. The company had revenue of $932 million for the quarter, compared to the consensus estimate of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. Xylem’s quarterly revenue was up 1.3% on a year-over-year basis. During the same period last year, the business posted $0.43 EPS. Equities analysts forecast that Xylem will post $2.04 EPS for the current year.
In other Xylem news, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Tomas Brannemo sold 8,524 shares of Xylem stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $50.06, for a total value of $426,711.44. The disclosure for this sale can be found here. Company insiders own 0.77% of the company’s stock.
A number of hedge funds have recently modified their holdings of the company. American Century Companies Inc. boosted its stake in shares of Xylem by 190.6% in the second quarter. American Century Companies Inc. now owns 1,161,281 shares of the company’s stock worth $51,851,000 after buying an additional 761,695 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Xylem by 8.9% in the second quarter. BlackRock Inc. now owns 538,184 shares of the company’s stock worth $24,030,000 after buying an additional 43,793 shares in the last quarter. BlackRock Fund Advisors boosted its stake in shares of Xylem by 5.2% in the second quarter. BlackRock Fund Advisors now owns 2,953,751 shares of the company’s stock worth $131,885,000 after buying an additional 147,067 shares in the last quarter. BlackRock Group LTD boosted its stake in shares of Xylem by 0.9% in the second quarter. BlackRock Group LTD now owns 1,816,427 shares of the company’s stock worth $81,103,000 after buying an additional 16,859 shares in the last quarter. Finally, US Bancorp DE boosted its stake in shares of Xylem by 6.3% in the second quarter. US Bancorp DE now owns 30,370 shares of the company’s stock worth $1,356,000 after buying an additional 1,787 shares in the last quarter. 84.70% of the stock is owned by institutional investors.
XYL has been the topic of several research reports. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a report on Monday, August 22nd. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $52.00 price objective (up from $46.00) on shares of Xylem in a report on Monday, June 20th. Canaccord Genuity restated a “hold” rating and set a $50.00 price objective (up from $45.00) on shares of Xylem in a report on Tuesday, August 16th. RBC Capital Markets set a $51.00 price objective on Xylem and gave the stock a “buy” rating in a report on Tuesday, August 16th. Finally, Royal Bank Of Canada lifted their price target on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a report on Tuesday, August 16th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Xylem currently has a consensus rating of “Hold” and an average price target of $45.00.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.